Top 12 Endoscopy Device Investors in the Nordics
Top 12 Endoscopy Device Investors in the Nordics
The endoscopy device industry in the Nordics is at the forefront of medical innovation. This sector includes manufacturers and suppliers of instruments used to visualize internal organs, offering products like flexible endoscopes, imaging systems, and surgical tools. With an emphasis on patient safety and minimally invasive procedures, companies are increasingly incorporating advanced technologies such as robotics and artificial intelligence. Growth prospects appear strong, driven by an aging population and rising demand for effective gastrointestinal care. Nordic corporations are also enhancing collaboration, leveraging regional expertise to further develop and refine their product offerings in the rapidly evolving healthcare market.
The investors in this list vary from venture capital firms to corporate entities, predominantly headquartered in Sweden and Finland. Ranging in size from small firms with 11-50 employees to large organizations with over 5000, they were mostly established between the late 20th century and early 21st century. Interestingly, many investors completed notable deals in 2024, with EQT Group and Novo Holdings leading in volume. This mix of investment sizes and strategies shows a concerted effort toward accelerating medical technology, particularly in the dynamic endoscopy sector.
Top 12 Endoscopy Device Investors in the Nordics
1. Novo Holdings
- Website: novoholdings.dk
- Type: Venture Capital
- Headquarters: Hellerup, Denmark
- Founded year: 1999
- Headcount: 51-200
- Number of deals in 2024: 45
- LinkedIn: novo-a-s
Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, focused on managing the assets of the Novo Nordisk Foundation. Founded in 1999, the firm invests in life science companies at various stages of development, providing capital and strategic support to enhance healthcare solutions. Notably, Novo Holdings has invested in several companies within the endoscopy device sector, including Apollo Endosurgery, which raised $47.6 million in a Series B funding round in 2012, and Minerva Surgical, which has raised significant capital for its innovative surgical solutions. Additionally, their investment in PROCEPT BioRobotics and involvement with ConvaTec further demonstrate their commitment to advancing medical technologies, including those related to endoscopy. With a total of 45 investments in 2024, Novo Holdings continues to play a significant role in the life sciences industry, making them a relevant investor in the endoscopy device market.
2. Almi
- Website: almi.se
- Type: Venture Capital
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1994
- Headcount: 201-500
- Number of deals in 2024: 7
- LinkedIn: almi-ab
Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It provides loans, risk capital, and business development support to small and medium-sized enterprises, aiming to enhance their growth and competitiveness through tailored financial solutions. Almi has been involved in several transactions within the medical technology sector, including investments in companies like Resitu Medical AB, which is focused on developing medical devices and aims for CE marking, and Developeration, a healthcare manufacturer of surgical methods and devices. These transactions highlight Almi's engagement in the medtech field, making them a relevant player in the endoscopy device market.
3. EQT Group
- Website: eqtgroup.com
- Type: Private Equity
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1994
- Headcount: 1001-5000
- Number of deals in 2024: 30
- LinkedIn: eqt-partners
EQT Group is a prominent investment firm founded in 1994, based in Stockholm, Sweden. It specializes in private equity, infrastructure, real estate, growth equity, and venture capital, serving institutional investors with expertise in managing diverse investment portfolios across multiple sectors and geographies. Notably, EQT has made significant investments in the healthcare sector, including the acquisition of Atos Medical in 2011, which supports growth strategies in healthcare markets. Other relevant transactions include the acquisition of HemoCue, a company focused on point-of-care blood testing equipment, indicating EQT's commitment to investing in medical technology and devices. These transactions highlight EQT's active role in the healthcare industry, making it a potential investor in endoscopy devices.
4. Nordic Capital
- Website: nordiccapital.com
- Type: Private Equity
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1989
- Headcount: 201-500
- Number of deals in 2024: 10
- LinkedIn: nordic-capital
Nordic Capital is a private equity firm based in Stockholm, Sweden, founded in 1989. The firm specializes in investments across various sectors, with a strong focus on healthcare and technology. Nordic Capital partners with management teams to drive growth and operational improvements in its portfolio companies, aiming to create long-term value and sustainability. Notably, Nordic Capital has been involved in significant transactions within the healthcare sector, including the acquisition of Atos Medical, a Swedish medical device company focused on rehabilitation solutions, which may relate to endoscopy technologies. Additionally, their acquisition of Corpuls, a medical technology company specializing in emergency medical solutions, further demonstrates their commitment to the healthcare industry. These transactions highlight Nordic Capital's active role in the medical device landscape, making them a relevant player in the endoscopy device investment space.
5. Investinor
- Website: investinor.no
- Type: Venture Capital
- Headquarters: Trondheim, Trøndelag, Norway
- Founded year: 2008
- Headcount: 11-50
- Number of deals in 2024: 4
- LinkedIn: investinor
Investinor AS is a venture capital investment company based in Trondheim, Trøndelag, Norway, founded in 2008. The firm specializes in providing funding to promising startups and companies, helping them grow and achieve market leadership. Investinor manages state interests in seed and venture funds and collaborates with entrepreneurs and other investors. Notable transactions include investments in CardioMech, which raised $18.5M for its catheter-based mitral valve repair technology, and Cimon Medical, a startup focused on ultrasound technology. These investments indicate Investinor's interest in innovative medical technologies, which may extend to endoscopy devices.
6. Indutrade Life Science
- Website: indutrade.se
- Type: Corporate
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1978
- Headcount: 1001-5000
- Number of deals in 2024: 14
- LinkedIn: indutrade-life-science
Indutrade Life Science is a corporate investor based in Stockholm, Sweden, founded in 1978. The firm is part of the larger Indutrade group, which focuses on developing and acquiring companies with high technical expertise across various technology and industrial sectors. Indutrade emphasizes long-term relationships with its customers and operates through a decentralized structure, allowing its subsidiaries to maintain independence while benefiting from the group's resources. Notable transactions include the acquisition of Medexa Diagnostisk Service AB in 2013, which may relate to diagnostic services in the medical field, and the acquisition of Oscar Medtec in 2022, a supplier of medical refrigerators and examination furniture. These transactions indicate Indutrade's active role in the medical technology sector, which could encompass endoscopy devices as part of their broader investment strategy.
7. AddLife AB
- Website: add.life
- Type: Corporate
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 2016
- Headcount: 1001-5000
- Number of deals in 2024: 3
- LinkedIn: addlife-ab
AddLife AB is a Swedish corporate investor based in Stockholm, founded in 2016, operating within the Life Science sector with a focus on Labtech and Medtech. The company provides high-quality medical technology products, assistive equipment, and laboratory solutions primarily to healthcare providers, hospitals, and research institutions across Europe. AddLife operates through a decentralized business model, allowing its subsidiaries to maintain flexibility while benefiting from the company's resources. Notably, AddLife has made several strategic acquisitions, including Emmat Medical in 2023, which is an independent distributor of surgical instruments in the UK, indicating their interest in the surgical and potentially endoscopy device market. Other acquisitions, such as Healthcare21 and Mediplast AB, further enhance their portfolio in the healthcare sector, positioning them as a significant player in the medical technology landscape.
8. Innovestor
- Website: innovestorgroup.com
- Type: Venture Capital
- Headquarters: Helsinki, Uusimaa, Finland
- Founded year: 2014
- Headcount: 11-50
- Number of deals in 2024: 12
- LinkedIn: innovestor
Innovestor is an investment management company based in Helsinki, Finland, specializing in venture capital, real estate, and energy storage. Founded in 2014, Innovestor focuses on providing funding and support to early-stage startups and corporations, particularly in technology and life sciences. They offer services such as investment advice, corporate venturing, and participation in accelerator programs. Innovestor has been involved in several relevant transactions in the medical device sector, including investments in Synoste Oy, a medical device company focused on clinical applications, and Surgify, which is developing a safer surgical drill. Additionally, their investment in HVR Cardio, a cardiovascular device company, and Monidor, a medtech startup, showcases their commitment to advancing medical technologies. These transactions highlight Innovestor's active role in the healthcare and medical device industries, making them a relevant investor in the endoscopy device space.
9. Covidien Finland Oy
- Website: covidien.com
- Type: Corporate
- Headquarters: Helsinki, Uusimaa, Finland
- Founded year: 2007
- Headcount: 51-200
- LinkedIn: covidien-finland-oy
Covidien Finland Oy, a corporate investor based in Helsinki, Uusimaa, Finland, is a subsidiary of Medtronic, a leading healthcare technology provider founded in 2007. The company specializes in innovative medical devices and therapies, focusing on enhancing treatment outcomes and improving patient care. Covidien has been involved in several significant acquisitions that bolster its position in the endoscopy device market. Notably, the acquisition of Given Imaging for approximately $860 million in 2013 expanded its gastrointestinal solutions business, which is crucial for endoscopic procedures. Other relevant acquisitions include BARRX Medical, which specializes in endoscopic therapies, and Scandius BioMedical, further demonstrating Covidien's commitment to advancing technologies in the endoscopy space. Through these strategic investments, Covidien aims to provide comprehensive solutions for complex medical conditions, particularly in the gastrointestinal domain.
10. ADDvise
- Website: addvisegroup.com
- Type: Corporate
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1989
- Headcount: 501-1000
- LinkedIn: addvisegroup
ADDvise Group AB is a corporate investor based in Stockholm, Sweden, specializing in advanced medical technology and laboratory solutions. Founded in 1989, the company serves healthcare facilities and research institutions by providing a range of products, including medical equipment and laboratory furniture. ADDvise operates with a decentralized business model, allowing its subsidiaries to maintain their entrepreneurial spirit while benefiting from corporate support. Recently, ADDvise has made significant strides in the endoscopy device sector, notably signing a Letter of Intent to acquire Innovative Endoscopy Components, LLC for an initial payment of USD 8.25 million, which highlights their commitment to expanding their presence in this market. This acquisition is expected to be completed in the second half of 2023, further solidifying ADDvise's role in the endoscopy device industry. Other acquisitions, such as Grupo Kolplast and Axelerist, also reflect their broader strategy in the medical technology field, but the focus on endoscopy through IEC is particularly relevant.
11. Investor AB
- Website: investorab.com
- Type: Venture Capital
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1916
- Headcount: 51-200
- Number of deals in 2024: 4
- LinkedIn: investor-ab
Investor AB is an investment holding company based in Stockholm, Sweden, founded in 1916. It manages a diverse portfolio of high-quality global companies, focusing on long-term investments and providing strategic support primarily in the pharmaceuticals, telecommunications, and industrial sectors. Notably, Investor AB has made significant investments in the healthcare sector, including the acquisition of Mölnlycke Health Care, which specializes in medical devices, including those relevant to endoscopy. In 2024, Investor AB, in collaboration with Morgan Stanley Principal Investments, agreed to acquire Mölnlycke Health Care Group AB, further solidifying its commitment to the healthcare industry. Additionally, their involvement in funding rounds for companies like Dermasensor indicates an active interest in innovative healthcare solutions, which may include endoscopy devices.
12. Voima Ventures
- Website: voimaventures.com
- Type: Venture Capital
- Headquarters: Helsinki, Uusimaa, Finland
- Founded year: 2019
- Headcount: 11-50
- Number of deals in 2024: 11
- LinkedIn: voima-ventures
Voima Ventures is a venture capital firm based in Helsinki, Finland, founded in 2019. The firm specializes in funding early-stage science-based innovations and deep tech ventures, with a focus on supporting startups in various sectors, including life sciences and advanced manufacturing. Voima Ventures has been active in the Nordic and Baltic regions, providing capital and expertise to help startups scale their solutions for global challenges. Notably, they invested in Monidor Oy, a Finnish medtech startup that raised €1 million to bring its Monidrop device to market, showcasing their involvement in the medical technology space. Additionally, they have participated in funding rounds for other health-related companies, such as MVision AI, which focuses on AI-powered solutions for cancer treatment. These transactions highlight Voima Ventures' commitment to advancing healthcare technologies, making them a potential player in the endoscopy device sector.
Endoscopy Device Insights: Key Investors in the Nordics
| Investor | Headquarter | Size | Founded | Deals 2024 |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | 51-200 | 1999 | 45 |
| Almi | Stockholm, Stockholm, Sweden | 201-500 | 1994 | 7 |
| EQT Group | Stockholm, Stockholm, Sweden | 1001-5000 | 1994 | 30 |
| Nordic Capital | Stockholm, Stockholm, Sweden | 201-500 | 1989 | 10 |
| Investinor | Trondheim, Trøndelag, Norway | 11-50 | 2008 | 4 |
| Indutrade Life Science | Stockholm, Stockholm, Sweden | 1001-5000 | 1978 | 14 |
| AddLife AB | Stockholm, Stockholm, Sweden | 1001-5000 | 2016 | 3 |
| Innovestor | Helsinki, Uusimaa, Finland | 11-50 | 2014 | 12 |
| Covidien Finland Oy | Helsinki, Uusimaa, Finland | 51-200 | 2007 | 0 |
| ADDvise | Stockholm, Stockholm, Sweden | 501-1000 | 1989 | 0 |
| Investor AB | Stockholm, Stockholm, Sweden | 51-200 | 1916 | 4 |
| Voima Ventures | Helsinki, Uusimaa, Finland | 11-50 | 2019 | 11 |
Want to find more investors focusing on the endoscopy device industry?
If you want to find more investors that are active in the endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.With Inven, you'll also get to know:
- Deal History: Number of deals and their sizes.
- Portfolio: Companies they've invested in.
- Contact data: Key dealmakers, including their emails and phonenumbers.
- ...and much more!
.jpg)
Trusted by 700+ companies
